Trial intelligence / Profile preview

Emergency vs Traditional Spacers for Salbutamol Delivery in Asthma

NCT06816342Phase 4Recruiting

Sponsor
Beni Suef University
Start
Nov 2024
Primary completion
Feb 2025
Countries
1
01

Overview

Phase 4, open-label trial in asthma (10 arms), sponsored by Beni Suef University. Primary endpoints: Total Emitted Dose (TED) at 3 months, Mass Median Aerodynamic Diameter at 3 months and 4 more. Started Nov 2024; status: recruiting.

02

Conditions

asthma

Beyond the preview

Go deeper on NCT06816342.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06816342.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call